Primatene Mist returns as OTC after seven years

8 November 2018 - Deborah Wilkes

Archived

The US Food and Drug Administration (FDA) has approved a new version of Primatene Mist (epinephrine) seven years after the OTC asthma inhaler was taken off the market.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: